SEC Form 4/A · accession 0001267602-18-000051
ALIMERA SCIENCES INC · ALIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David Holland
Officer — SVP of Sales and Marketing
Period of report
Jan 22, 2018
Accepted (ET)
Mar 30, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1,F2 | $1.16 | Jan 22, 2018 | A | 140,000 | A | — | Jan 21, 2028 | Common Stock | 140,000 | 140,000 | D |
Explanation of responses
- F1The Form 4 initially filed on January 25, 2018 inadvertently listed the number of derivative securities as 150,000 instead of 140,000, the correct number.
- F2This option shall vest in forty-eight equal monthly installments beginning on January 22, 2018, provided that the Reporting Person remains continuously employed by the Issuer through each vesting period.